Betahistine dihydrochloride.

 

Ménière's syndrome. This syndrome is usually characterized by dizziness, tinnitus, nausea, headache and is often accompanied by loss of hearing.
Symptomatic treatment of vestibular vertigo.

 

Hypersensitivity to any component of the product.

 

Patients suffering from pheochromocytoma or bronchial asthma need to be carefully monitored during the therapy.
Caution is advised also in the treatment of patients with a history of peptic ulcer.
Administration during pregnancy is discouraged, although there are no indications for harmful effects in animal testing.

 

In some cases mild gastric complaints have been observed. They can normally be dealt with by taking the dosage during meals or by lowering the dose.

 

24 mg to 48 mg per day, to be taken in 3 divided dosages. Prolonged treatment is necessary for optimal results.

 

for PDF files, a free viewer is downloadable on the Adobe Systems' World Wide Website